CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...
Phase 2
Golden, Colorado, United States and 22 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Denver, Colorado, United States and 131 other locations
radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a ...
Phase 3
Parker, Colorado, United States and 72 other locations
enzalutamide or abiraterone/prednisone alone in asymptomatic or mildly symptomatic subjects with progressive, metastatic castration-resistant prostate...
Phase 1, Phase 2
Denver, Colorado, United States of America and 23 other locations
An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC and SGC.
Phase 1
Denver, Colorado, United States and 9 other locations
plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...
Phase 2, Phase 3
Lone Tree, Colorado, United States and 105 other locations
patients with progressive metastatic castration-resistant prostate cancer (mCRPC).The following assessment of prostate cancer...
Phase 3
Denver, Colorado, United States and 57 other locations
therapy in participants with metastatic castration resistant prostate cancer (mCRPC). There will be ten cohorts in this study: Coho...
Phase 1, Phase 2
Aurora, Colorado, United States and 32 other locations
period and an additional 40-week safety extension period in men with prostate cancer, either metastatic castration-sensitive prostate...
Phase 1
Lakewood, Colorado, United States and 16 other locations
The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...
Phase 2
Aurora, Colorado, United States and 220 other locations
Clinical trials
Research sites
Resources
Legal